Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 4-cycloakylaminopyrazolo pyrimidine NMDA/NR2B antagonists

4-cycloakylaminopyrazolo pyrimidine NMDA/NR2B antagonists

US Patent 7452893 · Granted Nov 18, 2008

Estimated economic value: $97,411,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Hydroxypyrrolidine-substituted arylsulfonamide compounds with selective activity2025
Antimalarial agents2025
2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors2025
Antimalarial agents2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activi2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
Tetracyclic heterocycle compounds useful as HIV integrase inhibitors2024
Tricyclic heterocycle compounds useful as HIV integrase inhibitors2024
2-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitors2023
Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, composi2023
2-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitors2022
Tetracyclic heterocycle compounds useful as HIV integrase inhibitors2022